Australia markets closed

AbCellera Biologics Inc. (ABCL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
10.47-0.67 (-6.01%)
At close: 04:00PM EST
10.43 -0.04 (-0.38%)
After hours: 07:58PM EST
Currency in USD
Earnings estimateCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
No. of analysts7297
Avg. Estimate-0.01-0.090.63-0.4
Low estimate-0.1-0.130.5-0.48
High estimate0.09-0.060.94-0.33
Year ago EPS0.190.540.480.63
Revenue estimateCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
No. of analysts8298
Avg. Estimate49.06M19.96M516.41M118.46M
Low estimate22.49M11.78M486.38M59.5M
High estimate88M28.15M551M256M
Year ago sales139.33M316.58M375.2M516.41M
Sales growth (year/est)-64.80%-93.70%37.60%-77.10%
Earnings history30/12/202130/03/202229/06/202229/09/2022
Est. EPS0.190.38-0.020.04
Actual EPS0.190.54-0.020.08
Difference00.1600.04
Surprise %0.00%42.10%0.00%100.00%
EPS trendCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
Current estimate-0.01-0.090.63-0.4
7 days ago-0.01-0.090.63-0.4
30 days ago0-0.10.58-0.27
60 days ago0-0.110.53-0.32
90 days ago0-0.110.53-0.32
EPS revisionsCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/A1N/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesABCLIndustrySector(s)S&P 500
Current qtr.-105.30%N/AN/AN/A
Next qtr.-116.70%N/AN/AN/A
Current year31.30%N/AN/AN/A
Next year-163.50%N/AN/AN/A
Next 5 years (per annum)10.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A